Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
$0.02
+7.4%
$0.02
$0.01
$3.47
$1.14M1.57281,029 shs310,800 shs
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
$6.37
$0.38
$1.24
$26.05M0.91522,308 shs466,373 shs
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
$0.73
$0.66
$0.51
$0.99
$9.34M0.035,265 shsN/A
PFHOD
Pacific Health Care Organization
$1.25
-69.5%
$1.25
$1.11
$5.90
$16M0.941,720 shs2,100 shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
0.00%0.00%0.00%-11.02%-98.84%
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
0.00%0.00%0.00%0.00%0.00%
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
0.00%+16.86%+12.31%+3.87%-16.09%
PFHOD
Pacific Health Care Organization
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/AN/AN/AN/AN/A
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/A
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
$1.27M0.90N/AN/A($14.93) per share0.00
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/A$1.54 per shareN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
$5.63M1.66$0.06 per share11.60$0.84 per share0.87
PFHOD
Pacific Health Care Organization
$6.80M2.35$0.11 per share11.21$0.63 per share1.98

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
-$58.79M-$9.23N/AN/AN/AN/AN/A-175.11%5/10/2024 (Estimated)
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
-$27.47M-$0.41N/AN/AN/AN/A-27.24%-26.08%N/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
$770K$0.0514.60N/A13.62%7.12%6.61%5/16/2024 (Estimated)
PFHOD
Pacific Health Care Organization
$1.36MN/A0.00N/A16.87%14.47%12.96%N/A

Latest BXRX, PFHOD, CLBS, and PFHO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2024Q4 2023
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/A$0.02+$0.02$0.02N/A$1.64 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/AN/A
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/AN/AN/AN/AN/A
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/A
0.07
0.07
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
N/A
22.33
22.33
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
11.59
11.59
PFHOD
Pacific Health Care Organization
0.05
12.91
12.91

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
952.46 million52.41 millionNot Optionable
Caladrius Biosciences, Inc. stock logo
CLBS
Caladrius Biosciences
2760.58 million59.25 millionOptionable
Pacific Health Care Organization, Inc. stock logo
PFHO
Pacific Health Care Organization
3112.80 million4.92 millionNot Optionable
PFHOD
Pacific Health Care Organization
3912.80 millionN/ANot Optionable

BXRX, PFHOD, CLBS, and PFHO Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Baudax Bio logo

Baudax Bio

NASDAQ:BXRX
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.
Caladrius Biosciences logo

Caladrius Biosciences

NASDAQ:CLBS
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Pacific Health Care Organization logo

Pacific Health Care Organization

OTCMKTS:PFHO
Pacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, lien representation, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves self-administered employers, insurers, third-party administrators, municipalities, and others. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California.

Pacific Health Care Organization

OTCMKTS:PFHOD
Pacific Health Care Organization, Inc., together with its subsidiaries, provides specialty workers' compensation managed care services for self-administered employers, insurers, third party administrators, municipalities, and others in the United States. The company is involved in managing health care organizations (HCOs) and medical provider networks (MPNs); and negotiating legal agreements for the implementation of workers' compensation carve-outs for California clients/employers with collective bargaining units. It also offers HCO and MPN programs; medical case management services; and ancillary services, including utilization and medical bill review, lien representation, legal support, Medicare set aside, and network access services for workers' compensation claims. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Newport Beach, California.